Shanghai EpimAb Biotherapeutics Co., Ltd.
Quick facts
Phase 2 pipeline
- EMB-01 · Oncology
EMB-01 is an investigational monoclonal antibody targeting PD-1.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: